abstract |
The present invention relates to the radiolabelled compound of enantiomer (R, R) of 5-fluoro-3-4(-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol, as well as said compound for use in a method for in-vivo diagnosis of, in particular, a cholinergic neurodegenerative disease, for example chosen from the group consisting of Alzheimer's disease, dysmnesia, learning disabilities, schizophrenia, cognitive dysfunction, hyperactivity disorder, anxiety neurosis, depression, analgesia and Parkinson's disease. |